Dermata Therapeutics Files 8-K
Ticker: DRMAW · Form: 8-K · Filed: Sep 17, 2025 · CIK: 1853816
| Field | Detail |
|---|---|
| Company | Dermata Therapeutics, Inc. (DRMAW) |
| Form Type | 8-K |
| Filed Date | Sep 17, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, other-events
Related Tickers: DRMA
TL;DR
DRMA filed an 8-K, something happened, details TBD.
AI Summary
Dermata Therapeutics, Inc. filed an 8-K on September 17, 2025, reporting "Other Events." The filing does not contain specific details about the nature of these events, dollar amounts, or definitive dates beyond the filing date itself.
Why It Matters
This filing indicates a material event has occurred for Dermata Therapeutics, requiring disclosure to investors, though the specifics are not yet detailed.
Risk Assessment
Risk Level: medium — The lack of specific details in the 8-K creates uncertainty, which can be a medium risk for investors until more information is provided.
Key Players & Entities
- Dermata Therapeutics, Inc. (company) — Registrant
- September 17, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-40739 (filing_id) — SEC File Number
- 3525 Del Mar Heights Rd., #322, San Diego, CA 92130 (address) — Principal executive offices
- (858) 800-2543 (phone_number) — Registrant's telephone number
FAQ
What specific event(s) are being reported in this 8-K filing?
The filing is categorized under 'Other Events' but does not provide specific details about the nature of these events.
When was the earliest event reported in this filing?
The earliest event reported was on September 17, 2025.
What is Dermata Therapeutics, Inc.'s state of incorporation?
Dermata Therapeutics, Inc. is incorporated in Delaware.
What is the SEC file number for Dermata Therapeutics, Inc.?
The SEC file number is 001-40739.
What is the principal executive office address for Dermata Therapeutics, Inc.?
The principal executive office is located at 3525 Del Mar Heights Rd., #322, San Diego, CA 92130.
Filing Stats: 712 words · 3 min read · ~2 pages · Grade level 7 · Accepted 2025-09-17 06:05:11
Key Financial Figures
- $0.0001 — ch Registered Common Stock, par value $0.0001 per share DRMA The Nasdaq Capital M
Filing Documents
- form8-k.htm (8-K) — 58KB
- 0001493152-25-013815.txt ( ) — 265KB
- drma-20250917.xsd (EX-101.SCH) — 4KB
- drma-20250917_def.xml (EX-101.DEF) — 26KB
- drma-20250917_lab.xml (EX-101.LAB) — 36KB
- drma-20250917_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DERMATA THERAPEUTICS, INC. Dated: September 17, 2025 By: /s/ Gerald T. Proehl Name: Gerald T. Proehl Title: Chief Executive Officer